KR20230084190A - 국소 안과 조성물 - Google Patents

국소 안과 조성물 Download PDF

Info

Publication number
KR20230084190A
KR20230084190A KR1020237013835A KR20237013835A KR20230084190A KR 20230084190 A KR20230084190 A KR 20230084190A KR 1020237013835 A KR1020237013835 A KR 1020237013835A KR 20237013835 A KR20237013835 A KR 20237013835A KR 20230084190 A KR20230084190 A KR 20230084190A
Authority
KR
South Korea
Prior art keywords
ophthalmic composition
topical ophthalmic
atropine
topical
eye
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020237013835A
Other languages
English (en)
Korean (ko)
Inventor
진송 니
롱 양
Original Assignee
에이디에스 테라퓨틱스 엘엘씨
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에이디에스 테라퓨틱스 엘엘씨 filed Critical 에이디에스 테라퓨틱스 엘엘씨
Publication of KR20230084190A publication Critical patent/KR20230084190A/ko
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
KR1020237013835A 2020-10-08 2021-10-08 국소 안과 조성물 Pending KR20230084190A (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063089263P 2020-10-08 2020-10-08
US63/089,263 2020-10-08
US17/317,551 2021-05-11
US17/317,551 US11191751B1 (en) 2020-10-08 2021-05-11 Topical ophthalmological atropine free base compositions
PCT/US2021/054221 WO2022076852A1 (en) 2020-10-08 2021-10-08 Topical ophthalmological compositions

Publications (1)

Publication Number Publication Date
KR20230084190A true KR20230084190A (ko) 2023-06-12

Family

ID=78818588

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020237013835A Pending KR20230084190A (ko) 2020-10-08 2021-10-08 국소 안과 조성물

Country Status (11)

Country Link
US (2) US11191751B1 (https=)
EP (2) EP4225284B1 (https=)
JP (1) JP2023544853A (https=)
KR (1) KR20230084190A (https=)
CN (1) CN116390714A (https=)
AU (1) AU2021359003A1 (https=)
BR (1) BR112023006371A2 (https=)
CA (1) CA3193940A1 (https=)
ES (1) ES3063371T3 (https=)
MX (1) MX2023004065A (https=)
WO (1) WO2022076852A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10251875B2 (en) 2017-05-11 2019-04-09 Nevakar Inc. Atropine pharmaceutical compositions
US11191751B1 (en) * 2020-10-08 2021-12-07 Ads Therapeutics Llc Topical ophthalmological atropine free base compositions
MX2023009091A (es) 2021-02-03 2023-08-09 Ads Therapeutics Llc Composiciones oftalmologicas topicas.
KR20240136369A (ko) * 2022-01-21 2024-09-13 에이디에스 테라퓨틱스 엘엘씨 8-메틸-8-아자비사이클로[3.2.1] 옥탄-3-일의 에스테르 3-하이드록시-2-페닐프로파노에이트
JP2025541009A (ja) 2022-12-23 2025-12-17 ノバリック ゲーエムベーハー ヒヨスチアミンを含む半フッ化アルカン組成物
CN117982412B (zh) * 2024-02-04 2024-09-17 济川(上海)医学科技有限公司 一种醋克利定眼用组合物及其药物制剂和用途
WO2025259674A1 (en) * 2024-06-11 2025-12-18 Ads Therapeutics Llc Compositions and methods for delivery of pharmaceutical actives
WO2025264886A1 (en) * 2024-06-19 2025-12-26 Btv Holding, Llc Ophthalmic preparations and methods of use
WO2026011139A1 (en) * 2024-07-05 2026-01-08 Ads Therapeutics Llc Transient receptor potential melastatin 8 agonist-containing ocular conditions and uses thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070254914A1 (en) * 2006-05-01 2007-11-01 Non-Profit Organization Chang Gung Memorial Hospital Low-concentration atropine solution for preventing myopia progression and preparing method thereof
EP2335735A1 (en) * 2009-12-14 2011-06-22 Novaliq GmbH Pharmaceutical composition for treatment of dry eye syndrome
CN102526051A (zh) * 2012-03-09 2012-07-04 哈尔滨医科大学 一种治疗真菌性角膜炎的眼药膏
CN113679699B (zh) * 2012-09-12 2022-10-28 诺瓦利克有限责任公司 包含半氟化烷烃的混合物的组合物
US9421199B2 (en) * 2014-06-24 2016-08-23 Sydnexis, Inc. Ophthalmic composition
US11510931B2 (en) * 2016-09-28 2022-11-29 Medicon Pharmaceuticals, Inc. Compositions and methods for treating ophthalmic conditions
AU2017333420A1 (en) * 2016-09-28 2019-04-04 Novaliq Gmbh Compositions comprising a cannabinoid receptor binding ligand
BR112019012568A2 (pt) * 2016-12-22 2019-11-26 Novaliq Gmbh composições compreendendo tacrolimus para o tratamento de doenças intraoculares inflamatórias
WO2019068763A1 (en) * 2017-10-04 2019-04-11 Novaliq Gmbh OPHTHALMIC COMPOSITIONS COMPRISING F6H8
TW201932104A (zh) * 2017-11-03 2019-08-16 澳大利亞商布萊恩荷登視覺協會 用於控制及/或降低近視進展之醫藥組合物
SG11202102820VA (en) * 2018-10-12 2021-04-29 Novaliq Gmbh Ophthalmic composition for treatment of dry eye disease
WO2020152046A1 (en) * 2019-01-21 2020-07-30 Novaliq Gmbh Pharmaceutical composition for the treatment of ocular neovascularisation
CA3128224A1 (en) * 2019-02-01 2020-08-06 Aerie Pharmaceuticals, Inc. Compounds, compositions and methods for treatment of myopia
US11191751B1 (en) * 2020-10-08 2021-12-07 Ads Therapeutics Llc Topical ophthalmological atropine free base compositions
MX2023009091A (es) * 2021-02-03 2023-08-09 Ads Therapeutics Llc Composiciones oftalmologicas topicas.

Also Published As

Publication number Publication date
CN116390714A (zh) 2023-07-04
US20230355594A1 (en) 2023-11-09
EP4706766A2 (en) 2026-03-11
CA3193940A1 (en) 2022-04-14
EP4225284B1 (en) 2025-11-26
WO2022076852A1 (en) 2022-04-14
AU2021359003A1 (en) 2023-05-04
ES3063371T3 (en) 2026-04-16
US11191751B1 (en) 2021-12-07
EP4225284C0 (en) 2025-11-26
BR112023006371A2 (pt) 2023-05-09
JP2023544853A (ja) 2023-10-25
EP4225284A1 (en) 2023-08-16
MX2023004065A (es) 2023-05-03
AU2021359003A9 (en) 2024-06-13
EP4225284A4 (en) 2024-10-09

Similar Documents

Publication Publication Date Title
KR20230084190A (ko) 국소 안과 조성물
US12485177B2 (en) Topical ophthalmological compositions
Dubey et al. Formulation and evaluation of stimuli-sensitive hydrogels of timolol maleate and brimonidine tartrate for the treatment of glaucoma
KR20200128407A (ko) 네비볼롤을 포함하는 약제학적 조성물
CN110237233B (zh) 一种含有环孢素的眼用药物组合物、其制备方法及用途
Manna et al. Biodegradable chitosan and polylactic acid-based intraocular micro-implant for sustained release of methotrexate into vitreous: analysis of pharmacokinetics and toxicity in rabbit eyes
WO2016014437A1 (en) Ophthalmic compositions of rifamycins and uses thereof
US9561234B2 (en) Methods for treating diseases of the retina
Okka et al. Effects of latrunculin B on outflow facility, intraocular pressure, corneal thickness, and miotic and accommodative responses to pilocarpine in monkeys
Vale et al. Drugs and the Eye: Sponsored by the British Optical Association
CN102670499A (zh) 一种缓释型西罗莫司眼用制剂
US20260124305A1 (en) Topical ophthalmological compositions
JP2003512324A (ja) 眼疾患の処置のためのリバスチグミン
HK40086649A (zh) 局部眼科组合物
CN120093684A (zh) 局部眼科组合物
Zhang et al. Topical Application of Everolimus Attenuates Lens-Induced Myopia Through mTORC1 Suppression
WO2026018131A1 (en) Ocular compositions
HK40126394A (zh) 一种α-肾上腺素受体激动剂眼用组合物及其用途
WO2025259674A1 (en) Compositions and methods for delivery of pharmaceutical actives
CN120379673A (zh) 用于使结构蛋白交联的组合物和方法
KR19990080875A (ko) 갈라민을 유효성분으로 하는 근시예방 및 치료용 조성물

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20230424

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20241007

Comment text: Request for Examination of Application